Barriers to xenotransplantation

Nature Medicine

Volumn 1, Issue 9, 1995, Pages 869-873

  Bach, F H ^a   Robson, S C ^a   Winkler, H ^a   Ferran, C ^a   Stuhlmeier, K M ^a   Wrighton, C J ^a   Hancock, W W ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1BETA;

GRAFT REJECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; XENOGRAFT;

ANIMAL; ANTIBODIES, HETEROPHILE; COMPLEMENT ACTIVATION; CYTOKINES; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; GRAFT REJECTION; HUMAN; MODELS, BIOLOGICAL; PRIMATES; SPECIES SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029078508     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0995-869     Document Type: Article

References (38)

1. Bach, F.H., Turman, MA., Vercellotti, G.M., Platt, J.L and Dalmasso, A.P. Accommodation: A working paradigm for progressing toward discordant xenogTafting, Transplanta Proc. 23, 205-208 (1991).
2. Bach, F.H. et al. Endothelial cell activation and thromboregulation during xenograft rejection. Immunol. Rev. 141, 5-30 (1994).
3. Vanhove, B. and Bach, F.H. Human xenoreactive natural antibodies: Avidity and targets on porcine endothelial cells. Transplantation 56, 1251-1253 (1993).
4. Hofer, E. et al Pathways of procoagulation in discordant xenografting. Transplanta Proc. 26, 1322 (1994).
5. Robson S.C. et al. Mechanism of abnormal thromboregulation in xenograft rejection: loss of endothelial ecto-ADPase activity. Transplanta Proc, (in the press).
6. Russell, M.E. et al. Identification and upregula- tion of galactose JV-acetylgalactosamine macrophage lectin in rat cardiac allografts with arteriosclerosis. J. clin. Invest. 94, 722-730 (1994).
7. Hofer, E. et al. Candidate natural killer cell receptors. Immun. Today 13, 429-430 (1992).
8. Inverardi, L. et al. Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J. Immun. 149, 1416-1423 (1992).
9. Cozzi, E. and White, D.J.G. The generation of transgenic pigs as potential organ donors for humans, Nature Med. 1, 964-966 (1995).
10. Candinas D. et al. Delayed xenograft rejection (DXR) in complement-depleted T cell-deficient (nude) rat recipients of guinea pig cardiac xenografts. Transplanta Proc, (in the press).
11. Pober J.S. and Cotran R.S, The role of endothelial cells in inflammation. Transplantation 50, 537-544 (1991).
12. Coughlan, A.F., Berndt, M.C., Duntop, L.C. and Hancock, W.W. In vivo studies of P-selectin and platelet-activating factor during endotoxemia, accelerated allograft rejection, and discordant xenograft rejection. Transplanta Proc. 25, 2930-2931 (1993).
13. Mantovani, A., Bussolino, F. and Dejana, E. Cytokine regulation of endothelial cell function. FASEB J. 6, 2591-2599 (1992).
14. Gerritsen, M.E. and Bloor, C.M. Endothelial cell gene expression in response to injury. FASEB. 7, 523-532 (1993).
15. Bach, F.H. et al Discordant xenografting: A working model of problems and issues. Xeno 1, 8-16 (1993).
16. Lesnikoski, B.A. et al. Inhibition of platelet GPIIbllla prolongs survival of discordant xenografts. Transplanta Proc, (in the press).
17. Lesnikoski, B.A., Shaffer, D.A., van der Werf, W.J., Hancock, W.W. and Bach F.H. Endothelial and host mononuclear cell activation and cytokine expression during rejection of pig-to- baboon discordant xenografts. Transplanta Proc. 27, 290-291 (1995).
18. Peerschke, E.I.B., Reid, K.B.M. and Ghebrehiwet, B. Platelet activation by Clq results in the induction of aIIbJB3 integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activity, J. exp. Med. 178, 579-587 (1993).
19. Faint, R.W. Platelet-neutrophil interactions: their significance. Blood Rev. 6, 83-91 (1992).
20. Celi, A. et al. P-selectin induces the expression of tissue factor on monocytes. Proc. natn. Acad. Sci. U.S.A. 91, 8767-8771 (1994).
21. Tsuji T., Nagata K., Koike J., Todoroki N. and Irimura T. Induction of superoxide anion production from monocytes and neutrophils by activated platelets through the P-selectin-sialyl Lewis X interaction. J. Leukocyte Biol. 56, 583-587 (1994).
22. Esmon, C.T. Cell mediated events that control blood coagulation and vascular injury, Anna. Rev. Cell Biol. 9, 1-26 (1993).
23. Dalmasso, A.P., Vercellotti, G.M., Platt, J.L. and Bach, F.H. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation 52, 530-533(1991).
24. Fodor, W.L. and Squinto, S.P. Engineering of transgenic pigs for xenogeneic organ transplantation. Xeno 3, 23-26 (1995).
25. Cooper, D.K.C., et al. Identification of alpha- galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transplant. Immun. 1, 198-205 (1993).
26. Baeuerle, P.A. and Henkel, T. Function and activation of NF-KB in the immune system. Anna. Rev. Immun. 12, 141-179 (1994).
27. Baeuerle, P.A. and Baltimore, D. IKB: A specific inhibitor of the NF-KB transcription factor. Science 242, 541-546(1988).
28. Conway, E.M. and Rosenberg, R.D. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Molec. cell. Biol. 8, 5588-5592 (1988).
29. Esmon, C.T. The regulation of natural anticoagulant pathways. Science 235, 1348-1354 (1987).
30. Grey, S., Tsuchida, A., Orthner, C.L., Salem, H.H. and Hancock, W.W. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-y or phorbol ester. J. Immun. 153, 3664-3672 (1994).
31. Wrighton, C., Kopp, C.W., McShea, A., Vetr, H. and Bach, F.H. High-level expression of functional human thrombomodulin in cultured porcine aortic endothelial cells. Transplantn Proc. 27, 288-289 (1995).
32. Kopp C.W., Robson S.C., Hancock, W.W., Bach, F.H. and Geczy, C. Porcine endothelial tissue factor pathway inhibitor antagonizes human tissue factor but not factor Xa. Transplantn Proc. (in the press).
33. Pareti, F.I., Mazzucoto, M., Bottiri E, and Marrucci, P.M. Interaction of porcine von Willebrand factor with the platelet glycoproteins lb and IlbJIIIa complex, Br. J. Haematol. 82, 81-86 (1992).
34. McCurry, K.R. et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med. 1, 423-427 (1995).
35. Pruitt, S.K. et al. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation 52, 868 (1991).
36. Goodman, D.J., von Albertini, M. and Bach F.H. Human natural killer cells induce the expression of E-selectin and interleukin 8 mRNA in porcine endothelial cells, Transplantn Proc. (in the press).
37. Millan, M.T., Ferran, C., Stuhlmeier, K.M., Geczy, C. and Bach, F.H, Human monocytes activate porcine endothelial cells by direct cell contact involving TNFa. Transplantn Proc. (in the press).
38. Schaapherder, A.F.M. et al. Antibody-dependent cell-mediated cytotoxicity against porcine endothelium induced by a majority of human sera. Transplantation 57, 1376-1382 (1994).